Global Pharmacovigilance (PV) Outsourcing Market Research Report 2024

Report ID: 1895074 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Contract Research Organizations (CROs)
        1.2.3 Business Process Outsourcing (BPOs)
    1.3 Market by Application
        1.3.1 Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Premarketing Clinical Trial
        1.3.3 Post-marketing Clinical Practice
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pharmacovigilance (PV) Outsourcing Market Perspective (2017-2028)
    2.2 Pharmacovigilance (PV) Outsourcing Growth Trends by Region
        2.2.1 Pharmacovigilance (PV) Outsourcing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pharmacovigilance (PV) Outsourcing Historic Market Size by Region (2017-2022)
        2.2.3 Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2023-2028)
    2.3 Pharmacovigilance (PV) Outsourcing Market Dynamics
        2.3.1 Pharmacovigilance (PV) Outsourcing Industry Trends
        2.3.2 Pharmacovigilance (PV) Outsourcing Market Drivers
        2.3.3 Pharmacovigilance (PV) Outsourcing Market Challenges
        2.3.4 Pharmacovigilance (PV) Outsourcing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue
        3.1.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue (2017-2022)
        3.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2017-2022)
    3.2 Global Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pharmacovigilance (PV) Outsourcing Revenue
    3.4 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio
        3.4.1 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2021
    3.5 Pharmacovigilance (PV) Outsourcing Key Players Head office and Area Served
    3.6 Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service
    3.7 Date of Enter into Pharmacovigilance (PV) Outsourcing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance (PV) Outsourcing Breakdown Data by Type
    4.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2017-2022)
    4.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2023-2028)
5 Pharmacovigilance (PV) Outsourcing Breakdown Data by Application
    5.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2017-2022)
    5.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
    6.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
    6.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
    7.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
    7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
    8.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
    9.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
    9.3 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
    10.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Accenture
        11.1.1 Accenture Company Detail
        11.1.2 Accenture Business Overview
        11.1.3 Accenture Pharmacovigilance (PV) Outsourcing Introduction
        11.1.4 Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.1.5 Accenture Recent Development
    11.2 C3i Solutions
        11.2.1 C3i Solutions Company Detail
        11.2.2 C3i Solutions Business Overview
        11.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Introduction
        11.2.4 C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.2.5 C3i Solutions Recent Development
    11.3 Clintec
        11.3.1 Clintec Company Detail
        11.3.2 Clintec Business Overview
        11.3.3 Clintec Pharmacovigilance (PV) Outsourcing Introduction
        11.3.4 Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.3.5 Clintec Recent Development
    11.4 Covance
        11.4.1 Covance Company Detail
        11.4.2 Covance Business Overview
        11.4.3 Covance Pharmacovigilance (PV) Outsourcing Introduction
        11.4.4 Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.4.5 Covance Recent Development
    11.5 Deloitte Touche Tohmatsu Limited
        11.5.1 Deloitte Touche Tohmatsu Limited Company Detail
        11.5.2 Deloitte Touche Tohmatsu Limited Business Overview
        11.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Introduction
        11.5.4 Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.5.5 Deloitte Touche Tohmatsu Limited Recent Development
    11.6 ELC Group
        11.6.1 ELC Group Company Detail
        11.6.2 ELC Group Business Overview
        11.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Introduction
        11.6.4 ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.6.5 ELC Group Recent Development
    11.7 Ergomed
        11.7.1 Ergomed Company Detail
        11.7.2 Ergomed Business Overview
        11.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Introduction
        11.7.4 Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.7.5 Ergomed Recent Development
    11.8 iGATE Corporation
        11.8.1 iGATE Corporation Company Detail
        11.8.2 iGATE Corporation Business Overview
        11.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Introduction
        11.8.4 iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.8.5 iGATE Corporation Recent Development
    11.9 iMED Global Corporation
        11.9.1 iMED Global Corporation Company Detail
        11.9.2 iMED Global Corporation Business Overview
        11.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Introduction
        11.9.4 iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.9.5 iMED Global Corporation Recent Development
    11.10 IQVIA
        11.10.1 IQVIA Company Detail
        11.10.2 IQVIA Business Overview
        11.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Introduction
        11.10.4 IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.10.5 IQVIA Recent Development
    11.11 MarksMan Healthcare
        11.11.1 MarksMan Healthcare Company Detail
        11.11.2 MarksMan Healthcare Business Overview
        11.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Introduction
        11.11.4 MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.11.5 MarksMan Healthcare Recent Development
    11.12 Medpace Holdings
        11.12.1 Medpace Holdings Company Detail
        11.12.2 Medpace Holdings Business Overview
        11.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Introduction
        11.12.4 Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.12.5 Medpace Holdings Recent Development
    11.13 Novartis
        11.13.1 Novartis Company Detail
        11.13.2 Novartis Business Overview
        11.13.3 Novartis Pharmacovigilance (PV) Outsourcing Introduction
        11.13.4 Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.13.5 Novartis Recent Development
    11.14 Oracle Corporation
        11.14.1 Oracle Corporation Company Detail
        11.14.2 Oracle Corporation Business Overview
        11.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Introduction
        11.14.4 Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.14.5 Oracle Corporation Recent Development
    11.15 Parexel
        11.15.1 Parexel Company Detail
        11.15.2 Parexel Business Overview
        11.15.3 Parexel Pharmacovigilance (PV) Outsourcing Introduction
        11.15.4 Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.15.5 Parexel Recent Development
    11.16 PharmInvent
        11.16.1 PharmInvent Company Detail
        11.16.2 PharmInvent Business Overview
        11.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Introduction
        11.16.4 PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.16.5 PharmInvent Recent Development
    11.17 PrimeVigilance
        11.17.1 PrimeVigilance Company Detail
        11.17.2 PrimeVigilance Business Overview
        11.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Introduction
        11.17.4 PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.17.5 PrimeVigilance Recent Development
    11.18 Pure Drug Safety
        11.18.1 Pure Drug Safety Company Detail
        11.18.2 Pure Drug Safety Business Overview
        11.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Introduction
        11.18.4 Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.18.5 Pure Drug Safety Recent Development
    11.19 Sciformix
        11.19.1 Sciformix Company Detail
        11.19.2 Sciformix Business Overview
        11.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Introduction
        11.19.4 Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.19.5 Sciformix Recent Development
    11.20 SIRO Clinpharm
        11.20.1 SIRO Clinpharm Company Detail
        11.20.2 SIRO Clinpharm Business Overview
        11.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Introduction
        11.20.4 SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.20.5 SIRO Clinpharm Recent Development
    11.21 Symogen
        11.21.1 Symogen Company Detail
        11.21.2 Symogen Business Overview
        11.21.3 Symogen Pharmacovigilance (PV) Outsourcing Introduction
        11.21.4 Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
        11.21.5 Symogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Contract Research Organizations (CROs)
    Table 3. Key Players of Business Process Outsourcing (BPOs)
    Table 4. Global Pharmacovigilance (PV) Outsourcing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2017-2022)
    Table 8. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2023-2028)
    Table 10. Pharmacovigilance (PV) Outsourcing Market Trends
    Table 11. Pharmacovigilance (PV) Outsourcing Market Drivers
    Table 12. Pharmacovigilance (PV) Outsourcing Market Challenges
    Table 13. Pharmacovigilance (PV) Outsourcing Market Restraints
    Table 14. Global Pharmacovigilance (PV) Outsourcing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Pharmacovigilance (PV) Outsourcing Market Share by Players (2017-2022)
    Table 16. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2021)
    Table 17. Ranking of Global Top Pharmacovigilance (PV) Outsourcing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service
    Table 21. Date of Enter into Pharmacovigilance (PV) Outsourcing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2017-2022)
    Table 25. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2023-2028)
    Table 27. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2017-2022)
    Table 29. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2023-2028)
    Table 31. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Accenture Company Detail
    Table 42. Accenture Business Overview
    Table 43. Accenture Pharmacovigilance (PV) Outsourcing Product
    Table 44. Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 45. Accenture Recent Development
    Table 46. C3i Solutions Company Detail
    Table 47. C3i Solutions Business Overview
    Table 48. C3i Solutions Pharmacovigilance (PV) Outsourcing Product
    Table 49. C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 50. C3i Solutions Recent Development
    Table 51. Clintec Company Detail
    Table 52. Clintec Business Overview
    Table 53. Clintec Pharmacovigilance (PV) Outsourcing Product
    Table 54. Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 55. Clintec Recent Development
    Table 56. Covance Company Detail
    Table 57. Covance Business Overview
    Table 58. Covance Pharmacovigilance (PV) Outsourcing Product
    Table 59. Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 60. Covance Recent Development
    Table 61. Deloitte Touche Tohmatsu Limited Company Detail
    Table 62. Deloitte Touche Tohmatsu Limited Business Overview
    Table 63. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product
    Table 64. Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 65. Deloitte Touche Tohmatsu Limited Recent Development
    Table 66. ELC Group Company Detail
    Table 67. ELC Group Business Overview
    Table 68. ELC Group Pharmacovigilance (PV) Outsourcing Product
    Table 69. ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 70. ELC Group Recent Development
    Table 71. Ergomed Company Detail
    Table 72. Ergomed Business Overview
    Table 73. Ergomed Pharmacovigilance (PV) Outsourcing Product
    Table 74. Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 75. Ergomed Recent Development
    Table 76. iGATE Corporation Company Detail
    Table 77. iGATE Corporation Business Overview
    Table 78. iGATE Corporation Pharmacovigilance (PV) Outsourcing Product
    Table 79. iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 80. iGATE Corporation Recent Development
    Table 81. iMED Global Corporation Company Detail
    Table 82. iMED Global Corporation Business Overview
    Table 83. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product
    Table 84. iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 85. iMED Global Corporation Recent Development
    Table 86. IQVIA Company Detail
    Table 87. IQVIA Business Overview
    Table 88. IQVIA Pharmacovigilance (PV) Outsourcing Product
    Table 89. IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 90. IQVIA Recent Development
    Table 91. MarksMan Healthcare Company Detail
    Table 92. MarksMan Healthcare Business Overview
    Table 93. MarksMan Healthcare Pharmacovigilance (PV) OutsourcingProduct
    Table 94. MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 95. MarksMan Healthcare Recent Development
    Table 96. Medpace Holdings Company Detail
    Table 97. Medpace Holdings Business Overview
    Table 98. Medpace Holdings Pharmacovigilance (PV) OutsourcingProduct
    Table 99. Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 100. Medpace Holdings Recent Development
    Table 101. Novartis Company Detail
    Table 102. Novartis Business Overview
    Table 103. Novartis Pharmacovigilance (PV) OutsourcingProduct
    Table 104. Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 105. Novartis Recent Development
    Table 106. Oracle Corporation Company Detail
    Table 107. Oracle Corporation Business Overview
    Table 108. Oracle Corporation Pharmacovigilance (PV) OutsourcingProduct
    Table 109. Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 110. Oracle Corporation Recent Development
    Table 111. Parexel Company Detail
    Table 112. Parexel Business Overview
    Table 113. Parexel Pharmacovigilance (PV) OutsourcingProduct
    Table 114. Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 115. Parexel Recent Development
    Table 116. PharmInvent Company Detail
    Table 117. PharmInvent Business Overview
    Table 118. PharmInvent Pharmacovigilance (PV) OutsourcingProduct
    Table 119. PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 120. PharmInvent Recent Development
    Table 121. PrimeVigilance Company Detail
    Table 122. PrimeVigilance Business Overview
    Table 123. PrimeVigilance Pharmacovigilance (PV) OutsourcingProduct
    Table 124. PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 125. PrimeVigilance Recent Development
    Table 126. Pure Drug Safety Company Detail
    Table 127. Pure Drug Safety Business Overview
    Table 128. Pure Drug Safety Pharmacovigilance (PV) OutsourcingProduct
    Table 129. Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 130. Pure Drug Safety Recent Development
    Table 131. Sciformix Company Detail
    Table 132. Sciformix Business Overview
    Table 133. Sciformix Pharmacovigilance (PV) OutsourcingProduct
    Table 134. Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 135. Sciformix Recent Development
    Table 136. SIRO Clinpharm Company Detail
    Table 137. SIRO Clinpharm Business Overview
    Table 138. SIRO Clinpharm Pharmacovigilance (PV) OutsourcingProduct
    Table 139. SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 140. SIRO Clinpharm Recent Development
    Table 141. Symogen Company Detail
    Table 142. Symogen Business Overview
    Table 143. Symogen Pharmacovigilance (PV) OutsourcingProduct
    Table 144. Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
    Table 145. Symogen Recent Development
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmacovigilance (PV) Outsourcing Market Share by Type: 2021 VS 2028
    Figure 2. Contract Research Organizations (CROs) Features
    Figure 3. Business Process Outsourcing (BPOs) Features
    Figure 4. Global Pharmacovigilance (PV) Outsourcing Market Share by Application in 2021 & 2028
    Figure 5. Premarketing Clinical Trial Case Studies
    Figure 6. Post-marketing Clinical Practice Case Studies
    Figure 7. Other Case Studies
    Figure 8. Pharmacovigilance (PV) Outsourcing Report Years Considered
    Figure 9. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Pharmacovigilance (PV) Outsourcing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Pharmacovigilance (PV) Outsourcing Market Share by Region: 2021 VS 2028
    Figure 12. Global Pharmacovigilance (PV) Outsourcing Market Share by Players in 2021
    Figure 13. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue in 2021
    Figure 15. North America Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Pharmacovigilance (PV) Outsourcing Market Share by Country (2017-2028)
    Figure 17. United States Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Pharmacovigilance (PV) Outsourcing Market Share by Country (2017-2028)
    Figure 21. Germany Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Region (2017-2028)
    Figure 29. China Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Pharmacovigilance (PV) Outsourcing Market Share by Country (2017-2028)
    Figure 37. Mexico Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Country (2017-2028)
    Figure 41. Turkey Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Accenture Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 44. C3i Solutions Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 45. Clintec Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 46. Covance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 47. Deloitte Touche Tohmatsu Limited Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 48. ELC Group Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 49. Ergomed Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 50. iGATE Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 51. iMED Global Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 52. IQVIA Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 53. MarksMan Healthcare Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 54. Medpace Holdings Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 55. Novartis Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 56. Oracle Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 57. Parexel Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 58. PharmInvent Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 59. PrimeVigilance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 60. Pure Drug Safety Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 61. Sciformix Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 62. SIRO Clinpharm Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 63. Symogen Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
Frequently Asked Questions
Pharmacovigilance (PV) Outsourcing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmacovigilance (PV) Outsourcing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmacovigilance (PV) Outsourcing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Primary Cell Culture

Primary Cell Culture market is segmented by players, region (country), by Type and by Application ... Read More